유전자 재조합 대상포진 백신 무엇이 다를까?
Herpes zoster (HZ) affects about one in three persons in their life time. Compared with the general population, older adults with immune senescence and individuals who are immunocompromised therapy are at increased risk for HZ, and its debilitating complications. To prevent HZ, two HZ vaccines, zost...
Saved in:
| Published in | The Korean journal of medicine Vol. 99; no. 4; pp. 180 - 188 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | Korean |
| Published |
대한내과학회
01.08.2024
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1738-9364 2289-0769 |
| DOI | 10.3904/kjm.2024.99.4.180 |
Cover
| Abstract | Herpes zoster (HZ) affects about one in three persons in their life time. Compared with the general population, older adults with immune senescence and individuals who are immunocompromised therapy are at increased risk for HZ, and its debilitating complications. To prevent HZ, two HZ vaccines, zoster vaccine live (ZVL) and recombinant zoster vaccine (RZV) are available. RZV is The Korean Society of Infectious Diseases revised guidelines for HZ vaccine in 2023, and recommended to vaccinate with RZV for adults ≥ aged 50 years and for severely immunocompromised adults aged ≥ 18 years. RZV is more effective for prevention of HZ than ZVL. RZV is nonreplicating and is thus safe in immunocompromised patients. RZV has clinically acceptable safety profile. This review will help clinicians update knowledge about RZV and identify eligible subjects who may benefit from HZ vaccinations. |
|---|---|
| AbstractList | Herpes zoster (HZ) affects about one in three persons in their life time. Compared with the general population, older adults with immune senescence and individuals who are immunocompromised therapy are at increased risk for HZ, and its debilitating complications. To prevent HZ, two HZ vaccines, zoster vaccine live (ZVL) and recombinant zoster vaccine (RZV) are available.
RZV is The Korean Society of Infectious Diseases revised guidelines for HZ vaccine in 2023, and recommended to vaccinate with RZV for adults ≥ aged 50 years and for severely immunocompromised adults aged ≥ 18 years. RZV is more effective for prevention of HZ than ZVL. RZV is nonreplicating and is thus safe in immunocompromised patients. RZV has clinically acceptable safety profile. This review will help clinicians update knowledge about RZV and identify eligible subjects who may benefit from HZ vaccinations. KCI Citation Count: 0 Herpes zoster (HZ) affects about one in three persons in their life time. Compared with the general population, older adults with immune senescence and individuals who are immunocompromised therapy are at increased risk for HZ, and its debilitating complications. To prevent HZ, two HZ vaccines, zoster vaccine live (ZVL) and recombinant zoster vaccine (RZV) are available. RZV is The Korean Society of Infectious Diseases revised guidelines for HZ vaccine in 2023, and recommended to vaccinate with RZV for adults ≥ aged 50 years and for severely immunocompromised adults aged ≥ 18 years. RZV is more effective for prevention of HZ than ZVL. RZV is nonreplicating and is thus safe in immunocompromised patients. RZV has clinically acceptable safety profile. This review will help clinicians update knowledge about RZV and identify eligible subjects who may benefit from HZ vaccinations. |
| Author | Seong Yeon Park 박성연 |
| Author_xml | – sequence: 1 fullname: 박성연 – sequence: 2 fullname: Seong Yeon Park |
| BackLink | https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003106348$$DAccess content in National Research Foundation of Korea (NRF) |
| BookMark | eNo9kM1Kw0AAhBepYK19APGSixchcX-yu1kQpBR_qoWC9L4k6UZi2lQSL94UCx5a0It40VJBEaGHCr0IPpHZvoPRiqdh4JsZmGVQiLuxAmAVQYsIaG9GJx0LQ2xbQli2hRy4AIoYO8KEnIkCKCJOHFMQZi-BcpqGHiQQCdvGrAi29MNIj3p6eGvo4Vg_TWZ3b0Y2uNBXl7ObsX7tGdnkXfdHRjae6vtr_Tg1sv5z9vL59THYXgGLgdtOVflPS6C5u9Os7pv1xl6tWqmbkUOxKaDCTHDiowC1As_1qIKCuJ5yqEcIZR71fQ4Z48wXVAnuKgRp7pBiLnQdSEpgY14bJ4GM_FB23fBXj7sySmTlqFmTeSTfgjiH1-dwFKZnoYxbaVseVA4bP_9gxil3kI0Qzbm1fy6Vp0nYcZNzaSPIiCDkG3dvcyw |
| ContentType | Journal Article |
| DBID | HZB Q5X JDI ACYCR |
| DEWEY | 610 |
| DOI | 10.3904/kjm.2024.99.4.180 |
| DatabaseName | KISS(한국학술정보) Korean Studies Information Service System (KISS) B-Type KoreaScience Korean Citation Index |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | 유전자 재조합 대상포진 백신 무엇이 다를까? What is Different about Recombinant Herpes Zoster Vaccine? |
| EISSN | 2289-0769 |
| EndPage | 188 |
| ExternalDocumentID | oai_kci_go_kr_ARTI_10585202 JAKO202426757814115 4106393 |
| GroupedDBID | 5-W 8JR 8XY ALMA_UNASSIGNED_HOLDINGS EF. HZB Q5X 9ZL JDI ACYCR |
| ID | FETCH-LOGICAL-k852-90e26973c1f1dfbab5e093abe85b3356b5cc706676c95e97ae1056761e6a0a803 |
| ISSN | 1738-9364 |
| IngestDate | Sat Aug 02 03:11:32 EDT 2025 Wed Oct 02 02:14:40 EDT 2024 Tue May 13 02:11:21 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Language | Korean |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-k852-90e26973c1f1dfbab5e093abe85b3356b5cc706676c95e97ae1056761e6a0a803 |
| Notes | The Korean Association Of Internal Medicine KISTI1.1003/JNL.JAKO202426757814115 |
| OpenAccessLink | http://click.ndsl.kr/servlet/LinkingDetailView?cn=JAKO202426757814115&dbt=JAKO&org_code=O481&site_code=SS1481&service_code=01 |
| PageCount | 9 |
| ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_10585202 kisti_ndsl_JAKO202426757814115 kiss_primary_4106393 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-08 |
| PublicationDateYYYYMMDD | 2024-08-01 |
| PublicationDate_xml | – month: 08 year: 2024 text: 2024-08 |
| PublicationDecade | 2020 |
| PublicationTitle | The Korean journal of medicine |
| PublicationTitleAlternate | 대한내과학회지 (Korean J Med) |
| PublicationYear | 2024 |
| Publisher | 대한내과학회 |
| Publisher_xml | – name: 대한내과학회 |
| SSID | ssib030194426 ssib044750981 ssj0000314786 ssib051086639 |
| Score | 2.260212 |
| Snippet | Herpes zoster (HZ) affects about one in three persons in their life time. Compared with the general population, older adults with immune senescence and... |
| SourceID | nrf kisti kiss |
| SourceType | Open Website Open Access Repository Publisher |
| StartPage | 180 |
| SubjectTerms | Herpes zoster vaccine Recombinant zoster vaccine Zoster vaccine live 내과학 |
| Title | 유전자 재조합 대상포진 백신 무엇이 다를까? |
| URI | https://kiss.kstudy.com/ExternalLink/Ar?key=4106393 http://click.ndsl.kr/servlet/LinkingDetailView?cn=JAKO202426757814115&dbt=JAKO&org_code=O481&site_code=SS1481&service_code=01 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003106348 |
| Volume | 99 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | 대한내과학회지, 2024, 99(4), 719, pp.180-188 |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1NaxNBdIj14kWUKsaPsqB7Kht3d2Z29oEgu2lKbakKRqinZXa7KTWSSJpePIhiwUMLehEvWiIoIuTQQi-Cv8hs_4NvZjcfxh7Uy2Qy72XmzbzZt-9l3rxHyI0ELRNPAFgxQGIxkXLLb9jckoDv9xgkFUzdd1696y09ZMtrfK1UOpzwWtruxpXk2Yn3Sv6Hq9iGfFW3ZP-Bs6NOsQHryF8skcNY_hWPzVrVhKoZ2KqCpc90S80Ee76oBVUNc8wQkRZM4GYACAtNv6qcHBDmU9QmFcxfHGIL7Ekj4Y9CRyOF2L9uQpQwHwaxhK4sYEveJ4KZRuJmiF0FZghqoN-dB9XOXGl3hkcAhTo8fchfDI8Eq-FZQQcOGo4OWB6kKlHSIyzn7w-vHBV_YLhs5D6Xb7mJKetVwGVTLa6eDNJJNcE5CHQlQPwJkS2UyKZ5LPShTM-TLhV7l00IaCfPGzX94qBgM-R287EKTuCyCkCFVQrcqXjczFFaHT1FTrtCaM-A1ee1oQhDcQmMjTVaFU7RhvHVXq4SW3lFIFatLFCHCZ2PdDSP_OxdUXTzD3pQcUC7YgstKWVebKJC1Oo0JhSi-jlytrBkjCDfludJqdmeJbeyD72st5PtvzWy_X726eD43TdjsPcie_Xy-E0_-7pjDA4Os92eMegfZe9fZx-PjMHu58GXHz-_792-QOqLtXp1ySoSdFhNn7sW2KnrgaCJ03DWG7GMeWoDlXGKTzml3It5kgjtRJ0AT0HIFJV5_OaknrSlb9OLZKbVbqWXiJGqyIrr1BVMMhUOCRgqrpKD9CXavIlTJrNq3tHTPARLVDChTOb0OkSt9a0n0XKwcs_VOqdK0uAwNHbK5DouUNRMNiMVR119brSjZidCa_FOhOTgPGz38sm9XyFnxvv1KpnpdrbTa6iCduM5zfRfgTBreA |
| linkProvider | ISSN International Centre |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%EC%9C%A0%EC%A0%84%EC%9E%90+%EC%9E%AC%EC%A1%B0%ED%95%A9+%EB%8C%80%EC%83%81%ED%8F%AC%EC%A7%84+%EB%B0%B1%EC%8B%A0+%EB%AC%B4%EC%97%87%EC%9D%B4+%EB%8B%A4%EB%A5%BC%EA%B9%8C%3F&rft.jtitle=The+Korean+journal+of+medicine&rft.au=%EB%B0%95%EC%84%B1%EC%97%B0&rft.au=Seong+Yeon+Park&rft.date=2024-08-01&rft.pub=%EB%8C%80%ED%95%9C%EB%82%B4%EA%B3%BC%ED%95%99%ED%9A%8C&rft.issn=1738-9364&rft.volume=99&rft.issue=4&rft.spage=180&rft_id=info:doi/10.3904%2Fkjm.2024.99.4.180&rft.externalDocID=4106393 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1738-9364&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1738-9364&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1738-9364&client=summon |